HomeELVN • NASDAQ
add
Enliven Therapeutics Inc
Previous close
$28.02
Day range
$27.75 - $30.03
Year range
$9.84 - $30.03
Market cap
1.37B USD
Avg Volume
289.96K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 24.60M | 30.63% |
Net income | -19.95M | -19.31% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -24.52M | -30.73% |
Effective tax rate | -1.18% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 312.39M | 12.43% |
Total assets | 327.04M | 13.36% |
Total liabilities | 22.11M | 132.58% |
Total equity | 304.93M | — |
Shares outstanding | 47.24M | — |
Price to book | 4.34 | — |
Return on assets | -18.37% | — |
Return on capital | -19.74% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -19.95M | -19.31% |
Cash from operations | -20.44M | -69.60% |
Cash from investing | -33.66M | 77.78% |
Cash from financing | 1.81M | 164.04% |
Net change in cash | -52.29M | 68.57% |
Free cash flow | -2.04M | 72.77% |
About
Founded
2016
Headquarters
Website
Employees
52